CRON Earnings

CRON reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 41.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.01 by 0%. The stock experienced a -3.61% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CRON's earnings announcement on 2026-02-26, the stock price moved by -3.61% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CRON's stock price tends to shift by an average of -4.06% in the 10 days leading up to earnings and -0.42% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CRON's annual revenue to reach 47.66M, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CRON's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CRON's stock price typically moves by -4.06% in the 10 days before its earnings and -0.42% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of and revenue of 47.66M.

The earnings call reveals strong financial performance with record gross profit and adjusted EBITDA, supported by a robust balance sheet. The Q&A section provides additional insights into strategic plans, such as international expansion and product innovation. Concerns about gross margin risks in Europe are acknowledged, but the overall sentiment is positive due to growth prospects and strategic initiatives like the buyback program and new product developments, which are likely to result in a stock price increase.